Ables, Iannone, Moore & Associates »

G1 Therapeutics shares owned by Ables, Iannone, Moore & Associates

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Ables, Iannone, Moore & Associates from 13F filings

Historical chart of Ables, Iannone, Moore & Associates investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Ables, Iannone, Moore & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Ables, Iannone, Moore & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $14k 4.7k 3.05